Scholars@Duke
Chanjuan Shi

Chanjuan Shi

Professor of Pathology
Pathology
chanjuan.shi@duke.edu
40 Duke Medicine Circle, Box 3712 DUMC, Durham, NC 27710
40 Duke Medicine Circle, Box 3712 DUMC, Durham, NC 27710

Scholarly Works - Conferences

Abstract C025: Effect of Chemotherapy on Spatial Relationships in the Colorectal Cancer Immune Microenvironment

Conference Cancer Immunology Research · February 18, 2026 AbstractMicrosatellite stable (MSS) stage IV colorectal cancer (CRC) is treated with chemotherapy (CT) and targeted therapy, but resistance is common, with only a 13% 5-year overall survival, and more eff ... Full text Cite

S5530 Syphilitic Hepatitis Without Rash: A Diagnostic Challenge

Conference American Journal of Gastroenterology · October 2025 Full text Cite

Uncovering the role of oncogenic HER2 variants as drivers of pancreatic cancer.

Conference Journal of Clinical Oncology · February 2025 772Background: The therapeutic resistance of pancreatic ductal adenocarcinoma (PDAC) to conventional cytotoxic therapy unders ... Full text Cite

Multidimensional Immunophenotyping of Intraductal Papillary Mucinous Neoplasms Reveals Novel T Cell and Macrophage Signature.

Conference Ann Surg Oncol · November 2022 BACKGROUND: Intraductal papillary mucinous neoplasms (IPMN) are the only radiographically identifiable precursor to pancreatic adenocarcinoma, yet little is known about how these lesions progress to cancer. Inflammation has been associated with dysplastic ... Full text Link to item Cite

Abstract 588: Advanced molecular characterization of severe autoimmune toxicities associated with checkpoint inhibitor therapies

Conference Cancer Research · July 1, 2017 AbstractImmune checkpoint inhibitors (ICIs) have made a profound impact on the treatment of a variety of cancers. However, as with any systemic treatment, toxicities are inevitable. With most classes of canc ... Full text Cite

Abstract A16: Smad4 pathways modulate induction of the chemokine Ccl20 and repress inflammation-induced carcinogenesis in mouse colon

Conference Cancer Research · February 1, 2017 AbstractInflammation regulates many aspects of gut homeostasis but is also a key component of colon cancer progression. While TGFβ signaling is known to regulate inflammatory responses within immune cells, w ... Full text Cite

Frequent BRAF Mutations in Colonic High-Grade Neuroendocrine Carcinoma

Conference ANNALS OF SURGICAL ONCOLOGY · February 1, 2016 Link to item Cite

Deciphering EMAST and MSI in Colorectal Cancers

Conference JOURNAL OF MOLECULAR DIAGNOSTICS · November 1, 2015 Link to item Cite

Abstract A23: Oncogenic Ras induces inflammatory cytokine production by upregulating squamous cell carcinoma antigen (SerpinB3)

Conference Molecular Cancer Research · December 1, 2014 AbstractMounting evidence indicates that oncogenic Ras can modulate cell autonomous inflammatory cytokine production, although the underlying mechanism remains unclear. Here we show that squamous cell carcin ... Full text Cite

Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.

Conference Am J Surg Pathol · April 2014 BACKGROUND: In the pancreas, poorly differentiated neuroendocrine carcinomas include small cell carcinoma and large cell neuroendocrine carcinoma and are rare; data regarding their pathologic and clinical features are very limited. DESIGN: A total of 107 p ... Full text Link to item Cite

Translocator protein (TSPO) as an imaging target in pancreatic cancer

Conference JOURNAL OF NUCLEAR MEDICINE · February 1, 2013 Link to item Cite

A Personalized Medicine Approach to Lung Cancer and Melanoma

Conference LABORATORY INVESTIGATION · February 1, 2011 Link to item Cite

BENIGN NODAL NEVI FREQUENTLY HARBOR THE ACTIVATING V600E BRAF MUTATION

Conference JOURNAL OF CUTANEOUS PATHOLOGY · January 1, 2009 Link to item Cite

LigAmp: Sensitive detection of single nucleotide differences

Conference JOURNAL OF MOLECULAR DIAGNOSTICS · November 1, 2004 Link to item Cite